According to Oryzon Genomics's latest financial reports the company has โฌ79.92 Million in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $โฌ81.77 M | 12.68% |
2022-12-31 | $โฌ72.57 M | 1.84% |
2021-12-31 | $โฌ71.26 M | -6.15% |
2020-12-31 | $โฌ75.93 M | 24.21% |
2019-12-31 | $โฌ61.12 M | 35.47% |
2018-12-31 | $โฌ45.12 M | 31.06% |
2017-12-31 | $โฌ34.43 M | 51.49% |
2016-12-31 | $โฌ22.72 M | -17.63% |
2015-12-31 | $โฌ27.59 M | 98.61% |
2014-12-31 | $โฌ13.89 M |